Page 8 - Use Listing News Today

More than 180 million doses of Sinopharm and Sinovac COVID-19 vaccines have been shipped to 49 countries through COVAX, playing a crucial global role in boosting immunity and saving lives, a senior World Health Organization (WHO) official said on Thursday.

Sinopharm, Sinovac important part of COVAX vaccine initiative: WHO-

Sinopharm, Sinovac important part of COVAX vaccine initiative: WHO-

The SEC took the decision based on the Hyderabad-based company's application seeing permission to test its intranasal COVID vaccine on 5,000 subjects.

The Indian Council of Medical Research (ICMR) has approved seven at-home COVID test kits so far. Except one, all these tests are nasal swab-based tests.

The World Health Organization today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago.

Emphasising that the Omicron variant is infecting both vaccinated and unvaccinated people worldwide, WHO Chief Scientist Dr Soumya Swaminathan has said that it appears that vaccines are still proving to be effective because even though the numbers are going up exponentially in many countries, severity of the disease has not surged to a new level.

, WHO Chief Scientist Dr Soumya Swaminathan has said that it appears that vaccines are still proving to be effective because even though the numbers are going up exponentially in many countries, severity of the disease has not surged to a new level.

COVAX is a worldwide initiative working to ensure fair, equitable access to COVID-19 vaccines for every country that participates.

"As expected, T cell immunity holding up better against #Omicron. This will protect us against severe disease. Please get vaccinated if you have not," said Swaminathan in a tweet on Wednesday.